Lilly, AstraZeneca Re-Up Partnership

Posted: Updated:
(Image Courtesy: Lilly Oncology) (Image Courtesy: Lilly Oncology)
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has extended an agreement with another major pharmaceutical maker. The deal with AstraZeneca (NYSE: AZN) involves exploring potential cancer treatment combinations.

Lilly's contributions to the immuno-oncology partnership include taking the lead on study execution and both companies will contribute resources.

Lilly Oncology Senior Vice President of Product Development and Medical Affairs Richard Gaynor says "the expansion of Lilly's research partnership with AstraZeneca will explore the far-reaching potential of combining novel targeted therapies. Our respective pipelines afford multiple targeted options to create innovative combinations in immuno-oncology and beyond, that we hope will lead to future cancer treatment options."

Lilly has several additional partnerships underway involving combination clinical trials. A collaboration was started earlier this year between Lilly and AstraZeneca studying the combination of durvalumab and ramucirumab for patients with advanced solid tumors.

Earlier this month, Lilly also detailed partnerships with Innovent Biologics Inc. in China regarding drug development and with California-based ImaginAb Inc. on research.

This week, Lilly reported third quarter net income of $799.7 million, which was up from $500.6 million during the same period the previous year and exceeded analysts' expectations.

  • Perspectives

    • School District Raises Questions About ILEARN

      Like all schools in Indiana, we were disheartened at the ILEARN results for school year 2018. We would like to raise several questions concerning this test as it relates to college and career readiness for our students. The annual Indiana Statewide Assessment (this year’s ILEARN) has been developed to evaluate college and career readiness at all levels tested. We are very troubled by our lack of understanding of what indicators in the test evaluate...

    More
  • Most Popular Stories

    • School District Raises Questions About ILEARN

      Like all schools in Indiana, we were disheartened at the ILEARN results for school year 2018. We would like to raise several questions concerning this test as it relates to college and career readiness for our students. The annual Indiana Statewide Assessment (this year’s ILEARN) has been developed to evaluate college and career readiness at all levels tested. We are very troubled by our lack of understanding of what indicators in the test evaluate...

    • Purdue University ranks #7 for Best Value in a college education in the U.S., according to the Wall Street Journal

      Two Indiana Schools Break Top 50 List of Best Colleges

      The Wall Street Journal and the Times Higher Education magazine have released their annual list of the top 801 colleges and universities in the country. Two Hoosier universities are included in the top 50.

    • Purdue to Open Chick-Fil-A Amid Protests

      Citing overwhelming demand for Chick-fil-A’s food and services, Purdue University has announced it will allow the restaurant to open on campus. The university has been at the center of a debate over the Georgia-based food chain. 

    • (image courtesy of Pixabay/NIkolay Frolochkin

      State Revenue Ticks Higher in August

      Indiana revenue in August exceeded projections by nearly four percent. The Indiana State Budget Agency reports General Revenue funds last month hit $1.1 billion, 3.8 percent above projections. Sales tax revenue came in higher than anticipated at $693 million, more than three percent higher.

    • Photo courtesy of Crestwood Village

      Justus Rental Properties Details Closures

      Indianapolis-based Justus Rental Properties, Inc. has announced it will be closing its assisted living service line at Crestwood Village West and Crestwood Village East. The company is also is in the process of selling the both communities.